XORTX Therapeutics (XRTX) Receivables (2020 - 2026)
XORTX Therapeutics (XRTX) posted Receivables of $64633.0 for Q1 2026, down 19.38% on a QoQ basis from $80172.0 in Q4 2025, and up 274.64% year-over-year from $17252.0 in Q1 2025.
XORTX Therapeutics (XRTX) Receivables (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Receivables history runs 7 years deep, the most recent figure standing at $64633.0 for Q1 2026.
- Quarterly Receivables rose 274.64% year-over-year to $64633.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64633.0 (up 274.64% YoY) and the FY2025 annual result came in at $80172.0, up 354.57% from the prior year.
- Receivables was $64633.0 for Q1 2026 at XORTX Therapeutics, down from $80172.0 in the prior quarter.
- Across five years, Receivables topped out at $195583.2 in Q2 2022 and bottomed at $10860.0 in Q2 2025.
- A 5-year average of $55395.9 and a median of $36421.0 in 2023 frame the typical range for Receivables.
- Annual changes were most pronounced in 2023 — Receivables sank 84.45% — and 2025, when it surged 354.57%.
- XORTX Therapeutics' Receivables stood at $81575.1 in 2022, then slipped by 25.58% to $60711.0 in 2023, then slumped by 70.95% to $17637.0 in 2024, then soared by 354.57% to $80172.0 in 2025, then slipped by 19.38% to $64633.0 in 2026.
- Business Quant data shows XRTX's Receivables at $64633.0 in Q1 2026, $80172.0 in Q4 2025, and $22092.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | XORTX Therapeutics | 20.40 Mn | 20.40 Mn | - | 64,633.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,633.00 |
| Dec 31, 2025 | 80,172.00 |
| Sep 30, 2025 | 22,092.00 |
| Jun 30, 2025 | 10,860.00 |
| Mar 31, 2025 | 17,252.00 |
| Dec 31, 2024 | 17,637.00 |
| Sep 30, 2024 | 13,111.00 |
| Jun 30, 2024 | 22,807.00 |
| Mar 31, 2024 | 30,883.00 |
| Dec 31, 2023 | 60,711.00 |
| Sep 30, 2023 | 68,241.00 |
| Jun 30, 2023 | 30,414.00 |
| Mar 31, 2023 | 36,421.00 |
| Dec 31, 2022 | 81,575.12 |
| Sep 30, 2022 | 66,358.82 |
| Jun 30, 2022 | 195,583.19 |
| Mar 31, 2022 | 122,979.74 |
| Dec 31, 2021 | 40,887.75 |
| Dec 31, 2020 | 11,008.00 |